ArticleMolecular biology reports2026
Anatomical sampling site is not associated with TAS2R38 gene expression in chronic rhinosinusitis: A cross-sectional RT-qPCR study.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic rhinosinusitis (CRS) is a complex inflammatory condition affecting the sinonasal mucosa. The bitter taste receptor T2R38 (encoded by TAS2R38) is expressed on ciliated respiratory epithelial cells, detecting bacterial quorum-sensing acyl-homoserine lactones to stimulate nitric oxide production and accelerate mucociliary clearance. However, whether mucosal TAS2R38 transcript levels vary across distinct sinonasal anatomical niches remains unverified, raising concerns regarding potential sampling bias in translational airway research.
objectiveTo determine whether sinonasal mucosal TAS2R38 gene expression differs across anatomical sub-sites in patients with CRS undergoing functional endoscopic sinus surgery (ESS) and evaluate variance contributions between individual host biology and biopsy sites.
methodsIn this prospective cross-sectional study, 337 mucosal specimens were harvested from up to six anatomical sites (inferior turbinate, maxillary, ethmoid, frontal, and sphenoid sinuses, and nasal polyps) in 67 surgical CRS patients (EPOS 2020 criteria), alongside 29 non-inflammatory septal control specimens. Relative TAS2R38 mRNA expression was quantified by MIQE-compliant RT-qPCR normalized to GAPDH. Clustered paired [Formula: see text]data were evaluated using linear mixed-effects modeling with patient-specific random intercepts as the principal analytical framework, alongside sensitivity analyses and fold-difference calculations ([Formula: see text]).
resultsFollowing quality control (excluding 84 specimens due to strict cycle thresholds and minute fibrous tissue yield), 253 valid specimens across 55 patients were analyzed (inferior turbinate: n = 52; maxillary: n = 50; ethmoid: n = 49; polyps: n = 44; frontal: n = 43; sphenoid: n = 15). Mean [Formula: see text]values were comparable across subsites (range: 2.06 to 2.81; exploratory ANOVA F = 0.42, P = 0.834). In the principal linear mixed-effects model, anatomical sampling site was not associated with TAS2R38 expression ([Formula: see text]). Inter-individual biological variance ([Formula: see text]; ICC = 0.333) substantially exceeded intra-individual spatial variation. Robustness was verified across six sensitivity scenarios, including the exclusion of sphenoid tissues and multivariable adjustments for age and sex (P = 0.617). Diseased mucosa demonstrated an exploratory 2.48-fold upregulation relative to non-site-matched septal controls.
conclusionMucosal TAS2R38 mRNA expression shows no statistically significant association with anatomical sampling site in surgical CRS, with transcript variability driven predominantly by between-patient biological differences. These findings provide translational evidence supporting the potential utility of inferior turbinate biopsy as a pragmatic, accessible surrogate for investigating sinonasal chemosensory innate defense.
Indexed as
Identifiers
42809023What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.